Galapagos NV Hits New 5.2 Million Euro Milestone in GlaxoSmithKline Alliance

Bookmark and Share

Reuters -- Galapagos NV says has successfully identified a second pre-clinical candidate compound in its osteoarthritis alliance with GlaxoSmithKline ( GSK - news - people ). Galapagos also reached a milestone on another compound in the alliance. Together these milestones trigger payments totaling 5.2 million euros to Galapagos.

Back to news